Coronavirus Update - 07th August 2020

We would like to take this opportunity to thank our clients and staff for their continued support over this period of restricted movement. 

We remain open for business as usual and have started welcoming limited numbers of visitors to site

We fully comply with all government guidance on minimising the risks of COVID-19 and have published our risk assessment here

Paul Quigley joins advisory board of the Leeds’ EPSRC Centre for Doctoral Training in Molecules to Product

We are thrilled to announce that our Head of Drug Substance, Paul Quigley, has been invited to join the advisory board of the Leeds’ EPSRC Centre for Doctoral Training in Molecules to Product.

Paul will support the funding body as it recruits multidisciplinary students working on PhD projects that facilitate a move to a ‘design and supply’ culture in industry.

Find out more here




Discover how Arcinova can help

We provide a fully integrated approach to drug development, speak to our team and discover how we can help you fast forward to market.

GET IN TOUCH